Related Experiment Video

Updated: Apr 16, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

12.5K

MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88

Bin Song1, Chaoxiong Zhang, Gang Li

  • 1Department of Pancreatic Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China.

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|March 14, 2015
PubMed
Abstract

Insights

Low miR-940 levels correlate with poor survival in pancreatic cancer. This microRNA inhibits tumor growth by targeting MyD88, offering potential therapeutic insights for pancreatic ductal adenocarcinoma (PDAC).

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy.
  • MicroRNA (miRNA) dysregulation is implicated in cancer progression.
  • The specific role of miR-940 in PDAC pathogenesis was previously undefined.

Purpose of the Study:

  • To investigate the role of miR-940 in pancreatic ductal adenocarcinoma.
  • To determine the relationship between miR-940, Myeloid differentiation primary response gene (88) (MyD88), and patient survival.
  • To elucidate the molecular mechanism by which miR-940 affects PDAC growth.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure miR-940 levels in PDAC tissues and cell lines.
  • MiRNA mimics and antisense oligonucleotides (ASO) for miR-940 overexpression and knockdown.
  • MTT assays for cell proliferation, FACS analysis for apoptosis, and dual-luciferase reporter assays to confirm MyD88 as a target.

Main Results:

  • Lower miR-940 levels and higher MyD88 protein levels in PDAC tissues were associated with reduced patient survival.
  • Overexpression of miR-940 suppressed PDAC cell growth, while knockdown promoted it.
  • MiR-940 directly targets the 3' untranslated region (UTR) of MyD88.

Conclusions:

  • Reduced miR-940 and elevated MyD88 expression in PDAC contribute to tumor growth and are linked to poor patient prognosis.
  • MiR-940 inhibits PDAC cell proliferation by targeting and downregulating MyD88.
  • These findings highlight a novel miR-940/MyD88 axis in PDAC pathogenesis.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K